These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24076556)

  • 1. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management.
    St Peter WL; Wazny LD; Patel UD
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):656-62. PubMed ID: 24076556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inpatient pharmacists' patient referrals to a transitions-of-care pharmacist: Evaluation of an automated referral process.
    Kerstenetzky L; Heimerl KM; Hartkopf KJ; Hager DR
    J Am Pharm Assoc (2003); 2018; 58(5):540-546. PubMed ID: 30017369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.
    Milfred-Laforest SK; Chow SL; Didomenico RJ; Dracup K; Ensor CR; Gattis-Stough W; Heywood JT; Lindenfeld J; Page RL; Patterson JH; Vardeny O; Massie BM
    J Card Fail; 2013 May; 19(5):354-69. PubMed ID: 23663818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
    Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
    Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review.
    Stemer G; Lemmens-Gruber R
    BMC Nephrol; 2011 Jul; 12():35. PubMed ID: 21777480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy in chronic kidney disease: Health outcomes & pharmacy-based strategies to mitigate inappropriate polypharmacy.
    Onor IO; Ahmed F; Nguyen AN; Ezebuenyi MC; Obi CU; Schafer AK; Borghol A; Aguilar E; Okogbaa JI; Reisin E
    Am J Med Sci; 2024 Jan; 367(1):4-13. PubMed ID: 37832917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the implementability of clinical pharmacist interventions in patients with chronic kidney disease: an analysis of systematic reviews.
    Salgado TM; Correr CJ; Moles R; Benrimoj SI; Fernandez-Llimos F
    Ann Pharmacother; 2013 Nov; 47(11):1498-506. PubMed ID: 24259596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration Strategies of Pharmacists in Primary Care-Based Accountable Care Organizations: A Report from the Accountable Care Organization Research Network, Services, and Education.
    Joseph T; Hale GM; Eltaki SM; Prados Y; Jones R; Seamon MJ; Moreau C; Gernant SA
    J Manag Care Spec Pharm; 2017 May; 23(5):541-548. PubMed ID: 28448780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Therapy Management after Hospitalization in CKD: A Randomized Clinical Trial.
    Tuttle KR; Alicic RZ; Short RA; Neumiller JJ; Gates BJ; Daratha KB; Barbosa-Leiker C; McPherson SM; Chaytor NS; Dieter BP; Setter SM; Corbett CF
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):231-241. PubMed ID: 29295829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients.
    St Peter WL; Farley TM; Carter BL
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):498-503. PubMed ID: 21709550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying medication-related problems in pharmacist-run home visits.
    Chim C; Joseph V
    J Am Pharm Assoc (2003); 2021; 61(3):e114-e118. PubMed ID: 33485813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving inpatient discharge workflows through pharmacist pending discharge medication orders.
    Lee K; Nixon G; Niemi K; Rose A
    Am J Health Syst Pharm; 2023 Sep; 80(18):1264-1270. PubMed ID: 37343297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of pharmacist intervention model for chronic kidney disease patients; a prospective comparative study.
    Khokhar A; Khan YH; Mallhi TH; Khan HM; Alotaibi NH; Alzarea AI; Bokharee N
    Int J Clin Pharm; 2020 Apr; 42(2):625-634. PubMed ID: 32026352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' recommendations to improve care transitions.
    Haynes KT; Oberne A; Cawthon C; Kripalani S
    Ann Pharmacother; 2012 Sep; 46(9):1152-9. PubMed ID: 22872752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of transitions-of-care services through acute care and outpatient pharmacy collaboration.
    Gilmore V; Efird L; Fu D; LeBlanc Y; Nesbit T; Swarthout M
    Am J Health Syst Pharm; 2015 May; 72(9):737-44. PubMed ID: 25873621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol: Effectiveness of patient centered pharmacist care in improving medication adherence, clinical parameters and quality of life among hemodialysis patients.
    Paneerselvam GS; Aftab RA; Sirisinghe RG; Lai PSM; Lim SK
    PLoS One; 2022; 17(2):e0263412. PubMed ID: 35180236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing medication errors for adults in hospital settings.
    Ciapponi A; Fernandez Nievas SE; Seijo M; Rodríguez MB; Vietto V; García-Perdomo HA; Virgilio S; Fajreldines AV; Tost J; Rose CJ; Garcia-Elorrio E
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD009985. PubMed ID: 34822165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Positive Kidney Health": Implementation and design of a pharmacist-led intervention for patients at risk for development or progression of chronic kidney disease.
    Vu A; Nicholas SB; Waterman AD; Madievsky R; Cheng F; Chon J; Fu JY; Mangione CM; Norris KC; Duru OK
    J Am Pharm Assoc (2003); 2023; 63(2):681-689. PubMed ID: 36593152
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.